Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2147931 | 0.86 | TSHR (0.42) | TSHRLMNACYP2C9ALDH1A1KDM4E | |
| SCHEMBL159517 | 0.82 | ALDH1A1 (0.44) | TSHRLMNACYP2C9ALDH1A1KDM4E | |
| SCHEMBL18789276 | 0.81 | TSHR (0.37) | TSHRLMNACYP2C9ALDH1A1KDM4E | |
| SCHEMBL27961599 | 0.71 | TSHR (0.46) | TSHR | |
| SCHEMBL5551474 | 0.71 | KDM4E (0.36) | TSHRLMNACYP2C9ALDH1A1KDM4E | |
| SCHEMBL3851227 | 0.70 | TSHR (0.50) | TSHRLMNAALDH1A1KDM4EHPGD | |
| SCHEMBL1392715 | 0.69 | — | — | |
| SCHEMBL438928 | 0.68 | — | — | |
| SCHEMBL758910 | 0.68 | — | — | |
| SCHEMBL134403 | 0.68 | TSHR (0.41) | TSHRLMNACYP2C9ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3103155-B1 | SPECIFIC LITHIUM BATTERIES COMPRISING NON-AQUEOUS ELECTROLYTES BASED ON SULFONE COMPOUNDS | RENAULT SAS (FR) | 2017-11-22 | — | — | EP | claimed |
| US-20160359199-A1 | SPECIFIC LITHIUM BATTERIES COMPRISING NON-AQUEOUS ELECTROLYTES BASED ON SULFONE COMPOUNDS | RENAULT S.A.S (FR) | 2016-12-08 | — | — | US | claimed |
| CN-106104895-A | Specific lithium battery comprising a non-aqueous electrolyte based on sulfone compounds | 雷诺两合公司 | 2016-11-09 | — | — | CN | claimed |
| US-20110171539-A1 | Non-Aqueous Electrolyte for a High-Voltage Lithium Battery | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2011-07-14 | — | — | US | claimed |
| US-20160359199-A1 | SPECIFIC LITHIUM BATTERIES COMPRISING NON-AQUEOUS ELECTROLYTES BASED ON SULFONE COMPOUNDS | RENAULT S.A.S (FR) | 2016-12-08 | — | — | US | disclosed |
| CN-106104895-A | Specific lithium battery comprising a non-aqueous electrolyte based on sulfone compounds | 雷诺两合公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20150125762-A1 | LITHIUM ELECTROCHEMICAL STORAGE BATTERY OF THE LITHIUM/AIR TYPE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-07 | — | — | US | disclosed |
| US-8679686-B2 | Non-aqueous electrolyte for a high-voltage lithium battery | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-03-25 | — | — | US | disclosed |
| US-20110171539-A1 | Non-Aqueous Electrolyte for a High-Voltage Lithium Battery | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2011-07-14 | — | — | US | disclosed |
| US-20050059658-A1 | Pyridazinone | BAYER AKTIENGESELLSCHAFT (DE) | 2005-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059658-A1 | Pyridazinone | TYMP, TPMT, PDXK | TSHR 3882/4885LMNA 3488/4885CYP2C9 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.